2016 International Congress Archives - Page 34 of 207

12:30pm-2:00pm: Orthostatic tremor: Is deep brain stimulation better than spinal cord stimulation?

H.L. Chiang, Y. Tai, V.S.C. Fung, N. Mahant (Sydney, Australia)

Tremor · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: Ortostatic myoclonus: A report of four cases

Z.F. Aldaajani, F.C.F. Chang, N. Mahant, S.D. Kim, V.S.C. Fung (Sydney, Australia)

Myoclonus · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: Paediatric and adult-onset parkinsonism in Chediak-Higashi disease: A new family

M. Carecchio, E. Salsano, A. Legati, C. Lamperti, E. Corsini, B. Garavaglia, D. Pareyson, D. Ghezzi (Milan, Italy)

Genetics (NON-PD) · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: Parkinson’s disease characteristics in patients with Gaucher’s disease

A. Thaler, A. Mirelman, E. Shimoni, M. Victor, O. Assais, M. Grumberg, T. Gurevich, T. Shiner, M. Gana Weisz, A. Orr Urtreger, N. Giladi (Tel-Aviv, Israel)

Parkinson's disease: Genetics · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: Parkinson’s disease motor subtypes show similar deficits in inhibitory control

C.M. Tolleson, M. Turchan, N. van Wouwe, S.A. Wylie (Nashville, TN, USA)

Parkinson's disease: Pathophysiology · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: Parkinson’s disease onset on non-dominant side predicts greater motor disability

T.A. Finseth, S. Sillau, B. Berman (Aurora, CO, USA)

Parkinson's disease: Pathophysiology · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: Parkinson’s disease-associated Miro1 mutants cause mitochondrial dysfunction

D. Grossmann, D. Scheibner, J. Fitzgerald, W. Mätzler, L. Burbulla, R. Krüger (Belvaux, Luxembourg)

Therapy in movement disorders: Gene and cell-based therapies · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: Paroxysmal exercise-induced dystonia within the phenotypic spectrum of ECHS1 deficiency

M. Quadri, M. Skorvanek, S. Olgiati, M. Minneboo, J. Graafland, G.J. Breedveld, R. Bonte, Z. Ozgur, K. Schoonderwoerd, F.W. Verheijen, W.F.J. van Ijcken, H. Fen Chien, E. Reis Barbosa, H.C. Chang, S.C. Lai, T.H. Yeh, C.S. Lu, Y.H. Wu-Chou, A.J.A. Kievit, V. Han, Z. Gdovinova, R. Jech, R.M.W. Hofstra, G.J.G. Ruijter, W. Mandemakers, V. Bonifati (Rotterdam, Netherlands)

Rare genetic and metabolic diseases · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: Pathophysiological mechanisms of bone mass loss for osteoporosis prevalence in Parkinson’s disease

L.A. Leandro, H.A.G. Teive (Curitiba, Brazil)

Parkinson's disease: Pathophysiology · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: Persistent drug-induced parkinsonism with normal dopamine transporter imaging

J.W. Lee, J.Y. Hong, J.S. Oh, I. Lee, J.S. Kim, Y.H. Sohn, P.H. Lee (Wonju, Korea)

Drug-induced movement disorders · Exhibit Hall located in Hall B, Level 2